Skip to main content

Maintaining optimal male health involves a complex interplay of hormones, with testosterone playing a pivotal role in muscle mass, mood regulation, and energy levels. When testosterone levels decline due to factors such as pituitary gland dysfunction or testicular issues, men may experience symptoms like fatigue, reduced libido, and mood disturbances. Addressing these concerns through testosterone replacement therapy (TRT) can significantly enhance quality of life.

This guide covers TRT options available under Australia Pharmaceutical Benefits Scheme (PBS), their costs, and current prescribing trends.

PBS-Listed Testosterone Therapies

1. Injectable Formulations:

Testosterone Undecanoate (Reandron 1000): A long-acting injection (1 g/4 mL) administered every 10-14 weeks. PBS charge: $31.60.

Testosterone Enantate (Primoteston Depot): Previously available as a shorter-acting injection (250 mg/mL) every 2-3weeks. Note: Removed from PBS in 2018 but still available privately.

Testosterone Propionate, Phenylpropionate, Isocaproate, and Decanoate (Sustanon 250): A blend of testosterone esters designed for intramuscular injection, typically administered every 3 weeks. Note: Not listed on the PBS; available via private prescription.

2. Transdermal Gels and Creams:

Testosterone 1% Gel (Testogel): Available in sachets or a metered-dose pump. PBS charge: $31.60.

Testosterone 2% Gel (Testavan): Higher concentration gel in a metered-dose pump. PBS charge: $31.60.

Testosterone 5% Cream (AndroForte 5): A topical cream applied daily. PBS charge: $31.60.

3. Oral Formulations:

Testosterone Undecanoate Capsules (Andriol): Taken daily. Note: Oral TRT use has declined, now comprising ~5% of prescriptions.

Prescribing Trends and Costs

PBS data shows a 37% decline in TRT prescriptions since 2015, largely due to stricter prescribing guidelines. Despite this, TRT-related costs remain high due to the increasing use of long-acting injectables. By 2018, annual expenditure on TRT reached approximately $112,539 per 100,000 individuals.

4. Current TRT distribution:

Injectable Formulations: ~50% of prescriptions, with Reandron 1000 being the most widely used due to its extended dosing interval.

Transdermal Gels and Creams: ~30%, with Testogel being the most commonly prescribed topical option.

Oral Formulations: ~5%, reflecting declining preference.

Discussion

Choosing the right TRT depends on individual needs and treatment goals. Have you used any of these therapies? Share your experiences to discuss the best ways to maintain hormonal balance and promote male health.

Note: Information is based on data available up to February 2025. For the latest updates, consult the PBS website.